Involvement of sphingolipids in the endothelin-1 signal transduction mechanism in rat brain

Neuroscience Letters

Volumn 220, Issue 2, 1996, Pages 121-124

  Catalan R E ^a   Aragones M D ^b   Martinez A M ^b   Fernandez I ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Brain; Ceramide; Endothelin 1; Glycosphingolipids; Sphingomyelin

Indexed keywords

CERAMIDE; ENDOTHELIN 1; SPHINGOLIPID; SPHINGOMYELIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CEREBELLUM; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CERAMIDES; CEREBELLUM; CEREBRAL CORTEX; ENDOTHELIN-1; GLYCOSPHINGOLIPIDS; HYDROLYSIS; RATS; SIGNAL TRANSDUCTION;

EID: 0030582729     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13249-3     Document Type: Article

References (29)

1. [1] Abe, A., Radin, N.S. and Shayman, J.A., Induction of glucosylceramide synthase by synthase inhibitors and ceramide, Biochim. Biophys. Acta, 1299 (1996) 333-341.
2. [2] Bajjalich, S.M., Martin, T.F.J. and Floor, E., Synaptic vesicle ceramide kinase, J. Biol. Chem., 264 (1989) 14354-14360.
3. [3] Barone, F.C., Willette, R.N., Yue, T.-L. and Feurstein, G., Therapeutic effects of endothelin receptor antagonists in stroke, Neurol. Res., 17 (1995) 259-264.
4. [4] Blich, E.G. and Dyer, W.J., A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol., 39 (1959) 911-917.
5. [5] Catalán, R.E., Martínez, A.M. and Aragonés, M.D., Evidence for a role of somatostatin in lipid metabolism of liver and adipose tissue. Regul. Peptides. 8 (1984) 147-159.
6. [6] Catalán, R.E., Martínez, A.M., Aragonés, M.D. and Miguel, B.G., Selective time-dependent effects of insulin on brain phosphoinositide metabolism, Regul. Peptides. 32 (1991) 289-296.
7. [7] Catalán, R.E., Martínez, A.M., Aragonés, M.D. and Hernández, F., Endothelin stimulates myristocylated alanine-rich C-kinase substrate (MARCKS) phosphorylation in rat cerebellar slices, Neurosci. Lett., 194 (1995) 53-56.
8. [8] Catalán, R.E., Martínez, A.M., Aragonés, M.D., Fernández, I., Miguel, B.G., Pérez, M.J. and Calcerrada, M.C., Endothelin-stimulated phosphoinositide turnover and protein kinase C translocation in rat synaptosomes, Biochem. Mol. Biol. Int., 38 (1996) 7-14.
9. [9] Catalán, R.H., Martínez, A.M., Aragonés, M.D., Hernández, F. and Díaz, G., Endothelin stimulales protein phosphorylation in blood -brain barrier, Biochem. Biophys. Res. Commun., 219 (1996) 366-369.
10. [10] Catalán, R.F., Martínez, A.M., Aragonés, M.D., Martínez, A. and Díaz, G., Endothelin stimulates phosphoinositide hydrolysis and PAF synthesis in brain microvessels. J. Cerebral Blood Flow Metab., (1996) in press.
11. [11] Chao, MV., Ceramide: a potential second messenger in the nervous system, Mol. Cell. Neurosci., 6 (1995) 91-96.
12. [12] Coroneos, E., Martínez, M., McKenna, S and Kesler, M., Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines, J. Biol. Chem., 270 (1995) 23305-23309.
13. [13] Dressler, K.A. and Kolesnick, R. N., Ceramide-1-phosphate, a novel phospholipid in human leukemia (HL-60) cells, J. Biol. Chem., 265 (1990) 14917-14921.
14. [14] Furtiya, S., Ono, K. and Hirabayashi, Y., Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture. J. Neurochem., 65 (1995) 1551-1561.
15. A-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious rats. Neuropharmacology, 33 (1994) 1155-1166.
16. [16] Guiali, A. and Srimal, R.C., Endothelin mechanism in the central nervous system: a target for drug development. Drug Dev. Res., 26 (1992) 361-387.
17. [17] Hannun, Y.A., The sphingomyelin cycle and the second messenger function of ceramide, J. Biol. Chem., 269 (1994) 3125-3128.
18. 3H]D-aspartate from cultured cerebellar granule cells, Biochem. Biophys. Res. Commun., 117 (1990) 593-599.
19. [19] Meacci, H., Vasta, V., Farnararo, M. and Bruni, P., Bradykinin increases ceramide and sphingosine content in human fibroblasts: possible involvement of glycosphingolipids. Biochem. Biophys. Res. Commun., 221 (1996) 1-7.
20. 2+ in cultured cortical neurons, Biochem. Biophys. Res. Commun., 222 (1996) 494-498.
21. [21] Morrel, P. and Radin, N.S., Specificity in ceramide biosynthesis from long chain bases and various fatty acyl Coenzyme A's by brain microsomes, J. Neurochem., 245 (1970) 342-350.
22. (22) Noll, G., Wenzel, R.R. and Luscher, T.F., Endothelin and endothelin antagonist: potential role in cardiovascular and renal disease. Mol. Cell. Biochem., 157 (1996) 259-267.
23. [23] Pagotto, U., Arzberger, T., Hopfner, U., Sauer, J., Renner, U., Newton, C.J., Lange, M., Uhl, E., Weindl, A. and Stalla, G.K., Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. J. Clin. Invest., 96 (1995) 2017-2025.
24. [24] Schaeren-Wiemers, N. van der Bijl, P. and Schwab, M.E., The UDP-galactose/ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide, J. Neurochem., 65 (1995) 2267-2278.
25. [25] Smith, M.E., Labelling of lipids by radioactive amino acids in the central nervous system. J. Neurochem., 23 (1974) 435-438.
26. [26] Sokolovsky, M., Endothelin receptor subtypes and their role in transmembrane signaling mechanisms, Pharmacol. Ther. 68 (1995) 435-471.
27. [27] Spiegel, S. and Milstien, S., Sphingolipid metabolites: members of a new class of lipid second messengers, J. Membrane Biol., 146 (1995) 225-237.
28. [28] Van Veldhoven, P.P., Bishop, W.R., Yurivich, D.A. and Bell, R.M., Ceramide quantitation: evaluation of a mixed micellar assay using E. coli diacylglycerol kinase, Biochem. Mol. Biol. Int., 36 (1995) 21-30.
29. [29] Viani, P., Zini, I., Cerrato, G., Biagini, G., Agnati, L.F. and Cestaro, B., Effect of endothelin-1 induced ischemia on peroxidative damage and membrane properties in rat striatum synaptosomes, Neurochem. Res., 20 (1995) 689-695.